Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity.

Schreibelt G, Musters RJ, Reijerkerk A, de Groot LR, van der Pol SM, Hendrikx EM, Döpp ED, Dijkstra CD, Drukarch B, de Vries HE.

J Immunol. 2006 Aug 15;177(4):2630-7.

3.
4.

Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.

van der Laan LJ, van der Goes A, Wauben MH, Ruuls SR, Döpp EA, De Groot CJ, Kuijpers TW, Elices MJ, Dijkstra CD.

J Neurosci Res. 2002 Jan 15;67(2):191-9.

PMID:
11782963
5.

Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.

Morini M, Roccatagliata L, Dell'Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D, Pfeffer U, Marchese M, Noonan D, Mancardi G, Albini A, Uccelli A.

J Neuroimmunol. 2004 Mar;148(1-2):146-53.

PMID:
14975595
6.
7.

Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.

Ifergan I, Wosik K, Cayrol R, Kébir H, Auger C, Bernard M, Bouthillier A, Moumdjian R, Duquette P, Prat A.

Ann Neurol. 2006 Jul;60(1):45-55.

PMID:
16729291
8.

Interferon-beta directly influences monocyte infiltration into the central nervous system.

Floris S, Ruuls SR, Wierinckx A, van der Pol SM, Döpp E, van der Meide PH, Dijkstra CD, De Vries HE.

J Neuroimmunol. 2002 Jun;127(1-2):69-79.

PMID:
12044977
9.

Antioxidant therapy in multiple sclerosis.

Mirshafiey A, Mohsenzadegan M.

Immunopharmacol Immunotoxicol. 2009;31(1):13-29. doi: 10.1080/08923970802331943. Review.

PMID:
18763202
10.

Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis.

Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE.

J Exp Med. 2004 Dec 20;200(12):1667-72.

11.

Protective effects of peroxiredoxin-1 at the injured blood-brain barrier.

Schreibelt G, van Horssen J, Haseloff RF, Reijerkerk A, van der Pol SM, Nieuwenhuizen O, Krause E, Blasig IE, Dijkstra CD, Ronken E, de Vries HE.

Free Radic Biol Med. 2008 Aug 1;45(3):256-64. doi: 10.1016/j.freeradbiomed.2008.03.024. Epub 2008 Apr 16.

PMID:
18452719
12.

Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.

Li XB, Schluesener HJ.

Arch Immunol Ther Exp (Warsz). 2006 Jan-Feb;54(1):51-3. Epub 2006 Feb 13.

PMID:
16642257
14.

FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage.

Foster CA, Mechtcheriakova D, Storch MK, Balatoni B, Howard LM, Bornancin F, Wlachos A, Sobanov J, Kinnunen A, Baumruker T.

Brain Pathol. 2009 Apr;19(2):254-66. doi: 10.1111/j.1750-3639.2008.00182.x. Epub 2008 Jun 4.

PMID:
18540945
15.

Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study.

Floris S, Blezer EL, Schreibelt G, Döpp E, van der Pol SM, Schadee-Eestermans IL, Nicolay K, Dijkstra CD, de Vries HE.

Brain. 2004 Mar;127(Pt 3):616-27. Epub 2003 Dec 22.

16.

GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.

Prasad R, Giri S, Nath N, Singh I, Singh AK.

Glia. 2007 Jan 1;55(1):65-77.

PMID:
17019693
18.

Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors.

Folcik VA, Smith T, O'Bryant S, Kawczak JA, Zhu B, Sakurai H, Kajiwara A, Staddon JM, Glabinski A, Chernosky AL, Tani M, Johnson JM, Tuohy VK, Rubin LL, Ransohoff RM.

J Neuroimmunol. 1999 Jun 1;97(1-2):119-28.

PMID:
10408965
19.
20.

Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.

Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC.

Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15511-6. doi: 10.1073/pnas.0807656105. Epub 2008 Sep 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk